secwatch.observer — SEC 8-K summary
======================================

Issuer:     TAO Synergies Inc. (TAOX)
CIK:        0001571934
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001104659-22-120092
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Synaptogenix raises $15M from existing investors in private placement of preferred stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds of $15M from sale of Series B convertible preferred stock (initial conversion at $7.75/share) and warrants.
- Warrants to acquire up to 1,935,485 shares at $7.75; 5-year term; conversion price ~25% premium to prior close.
- Closing expected Nov 21, 2022; net proceeds for general corporate purposes.
- CEO cites strengthening balance sheet ahead of topline Phase 2 Alzheimer's trial results expected in December 2022.
- Preferred shares carry 7% annual dividend, redeemable in 15 monthly installments starting April 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1571934/000110465922120092/0001104659-22-120092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1571934/000110465922120092/tm2230905d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-120092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer